Related Experiment Video

Updated: Jul 19, 2026

A New Technique for Treating Low-risk Prostate Cancer—Super Active Surveillance
05:19

A New Technique for Treating Low-risk Prostate Cancer—Super Active Surveillance

Published on: November 7, 2025

Emerging strategies in the treatment of testis cancer

C J Logothetis1

  • 1Department of Genito-urinary Medical Oncology, M.D. Anderson Cancer Center, 1515 Holcombe, Box 13, Houston, TX 77030, USA. clogothe@notes.mdacc.tmc.edu

Current Opinion in Urology
|October 14, 2006
PubMed

Insights

Advances in testicular germ-cell tumor therapy mean cure is common. The focus now is on optimizing treatment selection, minimizing toxicity, and predicting outcomes for most patients with testicular cancer.

Area of Science:

  • Oncology
  • Urology
  • Medical Literature Review

Background:

  • Recent literature highlights significant progress in the study and treatment of testicular germ-cell tumors.
  • Current therapeutic strategies have shifted the focus from achieving cure to optimizing treatment and managing side effects.

Purpose of the Study:

  • To review the current state of the art in the diagnosis and management of testicular germ-cell tumors.
  • To identify key therapeutic dilemmas and outcomes in patients with different stages of germ-cell tumors.

Main Methods:

  • Comprehensive review of recent scientific literature on testicular germ-cell tumors.
  • Analysis of therapeutic approaches, outcomes, and challenges in patient management.

Main Results:

  • For most patients with germ-cell tumors, cure is achievable, shifting the therapeutic focus.
  • Therapeutic decisions for low-volume non-seminomatous germ-cell tumors and pure seminomas center on therapy selection, toxicity, and outcome prediction.
  • High cure rates are not consistently observed in patients with high-volume non-seminomatous germ-cell tumors.

Conclusions:

  • The management of testicular germ-cell tumors has evolved, with cure being a realistic goal for the majority of patients.
  • Optimizing treatment strategies to balance efficacy, toxicity, and accurate prognosis is crucial for improving patient care in testicular cancer.

More Related Videos

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer07:25

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer

Published on: March 6, 2018

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts10:27

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on: July 25, 2020

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Treatment Resistent Cancers02:56

Treatment Resistent Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Disorders of the Male Reproductive System01:20

Disorders of the Male Reproductive System

Men's health issues are increasingly recognized as significant, with several conditions posing common threats. Among these, testicular cancer is especially prevalent in younger men, particularly those aged 20 to 35 years. The disease often manifests as a painless mass in the testicles, sometimes accompanied by a sensation of heaviness or a dull ache.
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra. Symptoms...